Skip to main content
BBNXSector not reported

Beta Bionics, Inc. (BBNX) Insider Trading

In the last 90 days, 6 Beta Bionics, Inc. (BBNX) insiders reported no open-market purchases and 14 sales totaling $2,384,794. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 26, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 26, 2026Mark HopmanChief Commercial OfficerSale821$20.00$16,420
Oct 14, 2026Mark HopmanChief Commercial OfficerSale775$17.35$13,446
Oct 1, 2026Mark HopmanChief Commercial OfficerSale370$18.96$7,015
Sep 22, 2026Christy JonesDirectorSale6,430$23.00$147,890
Sep 16, 2026Mike MensingerChief Product OfficerSale2,650$22.00$58,300
Sep 16, 2026Mark HopmanChief Commercial OfficerSale30,779$20.13$619,640
Sep 14, 2026Mark HopmanChief Commercial OfficerSale775$15.52$12,028
Sep 9, 2026Mark HopmanChief Commercial OfficerSale36,870$18.46$680,723
Sep 3, 2026Sean SaintPresident & CEOSale5,641$20.08$113,259
Sep 2, 2026Steven Jon RussellChief Medical OfficerSale4,221$19.11$80,676

Common questions

BBNX insider trading FAQ

Are BBNX insiders buying or selling?
Over the last 90 days, BBNX insiders were net sellers, reporting $0.00 of open-market purchases and $2,384,794 of sales.
When was the last BBNX insider purchase?
No open-market insider purchase of Beta Bionics, Inc. stock was reported in the last 90 days.
Where does BBNX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Beta Bionics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.